 The FDA has approved a new Alzheimer's treatment by drug maker Eli Lilly that combats the buildup of plaque linked to the disease. The drug will be available within weeks and cost up to $32,000 for 12 months of treatment, lower if it's covered by insurance. And a stunning loss today at Wimbledon.